Trade Summary

5 months ago, Nichtberger Steven, serving as Pres, CEO at Cabaletta Bio, Inc. (CABA), purchased 45,000 shares at $2.24 per share, for a total transaction value of $100,778.00. Following this transaction, Nichtberger Steven now holds 1,394,483 shares of CABA.

This purchase represents a 3.00% increase in Nichtberger Steven's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, January 21, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, January 21, 2026 at 6:54 PM ET, meaning the disclosure happened on the same day as the trade.

Cabaletta Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.